{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:53:19Z","timestamp":1791305599568,"version":"4.3.1"},"reference-count":58,"publisher":"EDP Sciences","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1051\/medsci\/2007232173","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T11:25:48Z","timestamp":1299324348000},"page":"173-179","source":"Crossref","is-referenced-by-count":20,"title":["Les chimiokines\u00a0: un r\u00e9seau sophistiqu\u00e9 de guidage cellulaire"],"prefix":"10.1051","volume":"23","author":[{"given":"B\u00e9hazine","family":"Combadi\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Combadi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Deterre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"250","published-online":{"date-parts":[[2007,2,15]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Foussat A, Galanaud P, Emilie D. Les chimiokines et la longue marche des leucocytes.Med Sci (Paris)2000; 16 : 757\u201366.","DOI":"10.4267\/10608\/1728"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Cyster JG. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs.Annu Rev Immunol2005; 23 : 127\u201359.","DOI":"10.1146\/annurev.immunol.23.021704.115628"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Mantovani A. The chemokine system: redundancy for robust outputs.Immunol Today1999; 20 : 254\u20137.","DOI":"10.1016\/S0167-5699(99)01469-3"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Morange M. D\u00e9construction de la notion de g\u00e8ne.Med Sci (Paris)2004; 20 : 835\u20136.","DOI":"10.1051\/medsci\/20042010835"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Luster AD, Alon R, von Andrian UH. Immune cell migration in inflammation: present and future therapeutic targets.Nat Immunol2005; 6 : 1182\u201390.","DOI":"10.1038\/ni1275"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Rot A, Von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells.Ann Rev Imm.2004; 22 : 891\u2013928.","DOI":"10.1146\/annurev.immunol.22.012703.104543"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Springael JY, Urizar E, Parmentier M. Dimerization of chemokine receptors and its functional consequences.Cytokine Growth Factor Rev2005; 16 : 611\u201323.","DOI":"10.1016\/j.cytogfr.2005.05.005"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Bulenger S, Marullo S, Bouvier M. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation.Trends Pharmacol Sci2005; 26 : 131\u20137.","DOI":"10.1016\/j.tips.2005.01.004"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Jordan BA, Devi LA. G-protein-coupled receptor heterodimerization modulates receptor function.Nature1999; 399 : 697\u2013700.","DOI":"10.1038\/21441"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Percherancier Y, Berchiche YA, Slight I,et al.Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers.J Biol Chem2005; 280 : 9895\u2013903.","DOI":"10.1074\/jbc.M411151200"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"El-Asmar L, Springael JY, Ballet S,et al.Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers.Mol Pharmacol2005; 67 : 460\u20139.","DOI":"10.1124\/mol.104.003624"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Chen C, Li J, Bot G,et al.Heterodimerization and cross-desensitization between the [mu]-opioid receptor and the chemokine CCR5 receptor.Eur J Pharmacol2004; 483 : 175\u201386.","DOI":"10.1016\/j.ejphar.2003.10.033"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Lortat-Jacob H, Grosdidier A, Imberty A. Structural diversity of heparan sulfate binding domains in chemokines.Proc Natl Acad Sci USA2002; 99 : 1229\u201334.","DOI":"10.1073\/pnas.032497699"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Proudfoot AE, Handel TM, Johnson Z,et al.Glycosaminoglycan binding and oligomerization are essential for thein vivoactivity of certain chemokines.Proc Natl Acad Sci USA2003; 100 : 1885\u201390.","DOI":"10.1073\/pnas.0334864100"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Van Den Steen PE, Wuyts A, Husson SJ,et al.Gelatinase B\/MMP-9 and neutrophil collagenase\/MMP-8 process the chemokines human GCP-2\/CXCL6, ENA-78\/CXCL5 and mouse GCP-2\/LIX and modulate their physiological activities.Eur J Biochem2003; 270 : 3739\u201349.","DOI":"10.1046\/j.1432-1033.2003.03760.x"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Thelen M. Dancing to the tune of chemokines.Nat Immunol2001; 2 : 129\u201334.","DOI":"10.1038\/84224"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Roscic-Mrkic B, Fischer M, Leemann C,et al.RANTES (CCL5) utilizes the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement.Blood2003; 24 : 24.","DOI":"10.1182\/blood-2003-02-0488"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Moatti D, Faure S, Fumeron F,et al.Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease.Blood2001; 97 : 1925\u20138.","DOI":"10.1182\/blood.V97.7.1925"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Lavergne E, Labreuche J, Daoudi M,et al.Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovascular disease.Arterioscler Thromb Vasc Biol2005; 25 : 847\u201353.","DOI":"10.1161\/01.ATV.0000157150.23641.36"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Campbell DJ, Kim CH, Butcher EC. Chemokines in the systemic organization of immunity.Immunol Rev2003; 195 : 58\u201371","DOI":"10.1034\/j.1600-065X.2003.00067.x"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Muller G, Hopken UE, Lipp M. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity.Immunol Rev2003; 195 : 117\u201335.","DOI":"10.1034\/j.1600-065X.2003.00073.x"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Breitfeld D, Ohl L, Kremmer E,et al.Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production.J Exp Med2000; 192 : 1545\u201352.","DOI":"10.1084\/jem.192.11.1545"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"O\u2019Garra A, McEvoy LM, Zlotnik A. T-cell subsets: chemokine receptors guide the way.Curr Biol1998; 8 : R646\u20139.","DOI":"10.1016\/S0960-9822(07)00413-7"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Rabin RL, Park MK, Liao F,et al.Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling.J Immunol1999; 162 : 3840\u201350.","DOI":"10.4049\/jimmunol.162.7.3840"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Morris MA, Ley K. Trafficking of natural killer cells.Curr Mol Med2004; 4 : 431\u20138.","DOI":"10.2174\/1566524043360609"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Ancuta P, Moses A, Gabuzda D. Transendothelial migration of CD16+monocytes in response to fractalkine under constitutive and inflammatory conditions.Immunobiology2004; 209 : 11\u201320.","DOI":"10.1016\/j.imbio.2004.04.001"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Caux C, Vanbervliet B, Massacrier C,et al.Regulation of dendritic cell recruitment by chemokines.Transplantation2002; 73 : S7\u201311.","DOI":"10.1097\/00007890-200201151-00005"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Murphy PM. Viral exploitation and subversion of the immune system through chemokine mimicry.Nat Immunol2001; 2 : 116\u201322.","DOI":"10.1038\/84214"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Hatabu T, Kawazu S, Aikawa M,et al.Binding ofPlasmodium falciparum-infected erythrocytes to the membrane-bound form of Fractalkine\/CX3CL1.Proc Natl Acad Sci USA2003; 100 : 15942\u20136.","DOI":"10.1073\/pnas.2534560100"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Onuffer J, Horuk R. Chemokines, chemokine receptors and small-molecule antagonists : recent developments.Trends Pharmacol Sci2002; 23 : 459.","DOI":"10.1016\/S0165-6147(02)02064-3"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Reape TJ, Groot PH. Chemokines and atherosclerosis.Atherosclerosis1999; 147 : 213\u201325.","DOI":"10.1016\/S0021-9150(99)00346-9"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Bursill CA, Channon KM, Greaves DR. The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics.Curr Opin Lipidol2004; 15 : 145\u20139.","DOI":"10.1097\/00041433-200404000-00007"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Elsner J, Escher SE, Forssmann U. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.Allergy2004; 59 : 1243\u201358.","DOI":"10.1111\/j.1398-9995.2004.00710.x"},{"key":"R34","doi-asserted-by":"crossref","unstructured":"Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation.N Engl J Med2006; 354 : 610\u201321.","DOI":"10.1056\/NEJMra052723"},{"key":"R35","doi-asserted-by":"crossref","unstructured":"Hancock WW, Lu B, Gao W,et al.Requirement of the chemokine receptor CXCR3 for acute allograft rejection.J Exp Med2000; 192 : 1515\u201320.","DOI":"10.1084\/jem.192.10.1515"},{"key":"R36","doi-asserted-by":"crossref","unstructured":"Haskell CA, Hancock WW, Salant DJ,et al.Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection.J Clin Invest2001; 108 : 679\u201388.","DOI":"10.1172\/JCI200112976"},{"key":"R37","doi-asserted-by":"crossref","unstructured":"Gao W, Topham PS, King JA,et al.Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection.J Clin Invest2000; 105 : 35\u201344.","DOI":"10.1172\/JCI8126"},{"key":"R38","doi-asserted-by":"crossref","unstructured":"Gao W, Faia KL, Csizmadia V,et al.Beneficial effects of targeting CCR5 in allograft recipients.Transplantation2001; 72 : 1199\u2013205.","DOI":"10.1097\/00007890-200110150-00003"},{"key":"R39","doi-asserted-by":"crossref","unstructured":"Hancock WW, Wang L, Ye Q,et al.Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression.Curr Opin Immunol2003; 15 : 479\u201386.","DOI":"10.1016\/S0952-7915(03)00103-1"},{"key":"R40","doi-asserted-by":"crossref","unstructured":"Fischereder M, Luckow B, Hocher B,et al.CC chemokine receptor 5 and renal-transplant survival.Lancet2001; 357 : 1758\u201361.","DOI":"10.1016\/S0140-6736(00)04898-4"},{"key":"R41","doi-asserted-by":"crossref","unstructured":"Sgadari C, Angiolillo AL, Tosato G. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10.Blood1996; 87 : 3877\u201382.","DOI":"10.1182\/blood.V87.9.3877.bloodjournal8793877"},{"key":"R42","doi-asserted-by":"crossref","unstructured":"Salcedo R, and Oppenheim JJ. Role of chemokines in angiogenesis: CXCL12\/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses.Microcirculation2003; 10 : 359\u201370.","DOI":"10.1080\/mic.10.3-4.359.370"},{"key":"R43","doi-asserted-by":"crossref","unstructured":"Balkwill F. Cancer and the chemokine network.Nat Rev Cancer2004; 4 : 540\u201350.","DOI":"10.1038\/nrc1388"},{"key":"R44","unstructured":"Moran CJ, Arenberg DA, Huang CC,et al.RANTES expression is a predictor of survival in stage I lung adenocarcinoma.Clin Cancer Res2002; 8 : 3803\u201312."},{"key":"R45","doi-asserted-by":"crossref","unstructured":"Ohta M, Tanaka F, Yamaguchi H,et al.The high expression of Fractalkine results in a better prognosis for colorectal cancer patients.Int J Oncol2005; 26 : 41\u20137.","DOI":"10.3892\/ijo.26.1.41"},{"key":"R46","doi-asserted-by":"crossref","unstructured":"Rollins BJ, Sunday ME. Suppression of tumor formationin vivoby expression of the JE gene in malignant cells.Mol Cell Biol1991; 11 : 3125\u201331.","DOI":"10.1128\/MCB.11.6.3125"},{"key":"R47","doi-asserted-by":"crossref","unstructured":"Biragyn A, Kwak LW. B-cell malignancies as a model for cancer vaccines: from prototype protein to next generation genetic chemokine fusions.Immunol Rev1999; 170 : 115\u201326.","DOI":"10.1111\/j.1600-065X.1999.tb01333.x"},{"key":"R48","doi-asserted-by":"crossref","unstructured":"Caux C, Ait-Yahia S, Chemin K,et al.Dendritic cell biology and regulation of dendritic cell trafficking by chemokines.Springer Semin Immunopathol2000; 22 : 345\u201369.","DOI":"10.1007\/s002810000053"},{"key":"R49","doi-asserted-by":"crossref","unstructured":"Merad M, Fong L, Bogenberger J,et al.Differentiation of myeloid dendritic cells into CD8alpha-positive dendritic cellsin vivo.Blood2000; 96 : 1865\u201372.","DOI":"10.1182\/blood.V96.5.1865.h8001865_1865_1872"},{"key":"R50","doi-asserted-by":"crossref","unstructured":"Shedlock DJ, Weiner DB. DNA vaccination: antigen presentation and the induction of immunity.J Leukoc Biol2000; 68 : 793\u2013806.","DOI":"10.1189\/jlb.68.6.793"},{"key":"R51","doi-asserted-by":"crossref","unstructured":"Scheerlinck JY. Genetic adjuvants for DNA vaccines.Vaccine2001; 19 : 2647\u201356.","DOI":"10.1016\/S0264-410X(00)00495-3"},{"key":"R52","doi-asserted-by":"crossref","unstructured":"Xin KQ, Lu Y, Hamajima K,et al.Immunization of RANTES expression plasmid with a DNA vaccine enhances HIV-1-specific immunity.Clin Immunol1999; 92 : 90\u20136.","DOI":"10.1006\/clim.1999.4730"},{"key":"R53","doi-asserted-by":"crossref","unstructured":"Sozzani S. Dendritic cell trafficking: more than just chemokinesCytokine Growth Factor Rev2005; 16 : 581\u201392.","DOI":"10.1016\/j.cytogfr.2005.04.008"},{"key":"R54","doi-asserted-by":"crossref","unstructured":"Moser B, Wolf M, Walz A,et al.Chemokines: multiple levels of leukocyte migration control.Trends Immunol2004; 25 : 75\u201384.","DOI":"10.1016\/j.it.2003.12.005"},{"key":"R55","doi-asserted-by":"crossref","unstructured":"O\u2019Garra A, McEvoy LM, Zlotnik A. T-cell subsets: chemokine receptors guide the wayCurr Biol1998; 8 : R646\u20139.","DOI":"10.1016\/S0960-9822(07)00413-7"},{"key":"R56","doi-asserted-by":"crossref","unstructured":"Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties.Immunity2003; 19 : 71\u201382.","DOI":"10.1016\/S1074-7613(03)00174-2"},{"key":"R57","doi-asserted-by":"crossref","unstructured":"Ancuta P, Rao R, Moses A,et al.Fractalkine preferentially mediates arrest and migration of CD16+monocytes.J Exp Med2003; 197 : 1701\u20137.","DOI":"10.1084\/jem.20022156"},{"key":"R58","doi-asserted-by":"crossref","unstructured":"Maghazachi AA. Compartmentalization of human natural killer cells.Mol Immunol2005; 42 : 523\u20139.","DOI":"10.1016\/j.molimm.2004.07.036"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2007232173\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T14:18:55Z","timestamp":1685974735000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2007232173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":58,"journal-issue":{"issue":"2"},"alternative-id":["medsci2007232p173"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/2007232173","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}